A detailed history of Huntington National Bank transactions in Novartis Ag stock. As of the latest transaction made, Huntington National Bank holds 21,544 shares of NVS stock, worth $2.29 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
21,544
Previous 23,133 6.87%
Holding current value
$2.29 Million
Previous $2.34 Million 10.79%
% of portfolio
0.02%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$95.27 - $108.47 $151,384 - $172,358
-1,589 Reduced 6.87%
21,544 $2.08 Million
Q4 2023

Feb 07, 2024

SELL
$92.27 - $101.54 $6,366 - $7,006
-69 Reduced 0.3%
23,133 $2.34 Million
Q3 2023

Nov 08, 2023

BUY
$94.73 - $105.13 $28,324 - $31,433
299 Added 1.31%
23,202 $2.36 Million
Q2 2023

Aug 11, 2023

SELL
$92.52 - $104.91 $22,759 - $25,807
-246 Reduced 1.06%
22,903 $2.31 Million
Q1 2023

May 10, 2023

SELL
$80.03 - $92.81 $72,507 - $84,085
-906 Reduced 3.77%
23,149 $2.13 Million
Q4 2022

Feb 09, 2023

SELL
$75.55 - $92.52 $187,666 - $229,819
-2,484 Reduced 9.36%
24,055 $2.18 Million
Q3 2022

Nov 07, 2022

SELL
$74.61 - $87.26 $79,310 - $92,757
-1,063 Reduced 3.85%
26,539 $2.02 Million
Q2 2022

Aug 09, 2022

SELL
$80.52 - $93.75 $35,348 - $41,156
-439 Reduced 1.57%
27,602 $2.33 Million
Q1 2022

May 10, 2022

BUY
$80.11 - $90.62 $6,088 - $6,887
76 Added 0.27%
28,041 $2.46 Million
Q4 2021

Jan 21, 2022

SELL
$79.7 - $88.13 $9,404 - $10,399
-118 Reduced 0.42%
27,965 $2.45 Million
Q3 2021

Oct 28, 2021

BUY
$81.78 - $95.14 $288,274 - $335,368
3,525 Added 14.35%
28,083 $2.3 Million
Q2 2021

Jul 30, 2021

BUY
$85.24 - $94.15 $607,761 - $671,289
7,130 Added 40.91%
24,558 $2.24 Million
Q1 2021

Apr 12, 2021

BUY
$83.5 - $98.47 $5,511 - $6,499
66 Added 0.38%
17,428 $1.49 Million
Q4 2020

Jan 11, 2021

SELL
$78.07 - $94.43 $137,247 - $166,007
-1,758 Reduced 9.19%
17,362 $1.64 Million
Q3 2020

Oct 30, 2020

SELL
$82.14 - $91.0 $37,209 - $41,223
-453 Reduced 2.31%
19,120 $1.66 Million
Q2 2020

Jul 30, 2020

SELL
$80.93 - $91.1 $49,448 - $55,662
-611 Reduced 3.03%
19,573 $1.71 Million
Q1 2020

Apr 27, 2020

SELL
$70.67 - $99.01 $76,111 - $106,633
-1,077 Reduced 5.07%
20,184 $1.66 Million
Q4 2019

Jan 17, 2020

BUY
$84.35 - $95.37 $212,815 - $240,618
2,523 Added 13.46%
21,261 $2.01 Million
Q3 2019

Nov 01, 2019

SELL
$85.54 - $94.26 $85,882 - $94,637
-1,004 Reduced 5.09%
18,738 $1.63 Million
Q2 2019

Jul 23, 2019

SELL
$75.4 - $92.8 $272,797 - $335,750
-3,618 Reduced 15.49%
19,742 $1.8 Million
Q1 2019

Apr 09, 2019

SELL
$75.32 - $86.15 $115,465 - $132,067
-1,533 Reduced 6.16%
23,360 $2.25 Million
Q4 2018

Jan 28, 2019

SELL
$73.66 - $82.02 $130,599 - $145,421
-1,773 Reduced 6.65%
24,893 $2.14 Million
Q3 2018

Oct 18, 2018

BUY
$66.94 - $77.43 $53,351 - $61,711
797 Added 3.08%
26,666 $2.3 Million
Q2 2018

Jul 19, 2018

BUY
$64.91 - $73.36 $10,125 - $11,444
156 Added 0.61%
25,869 $1.95 Million
Q1 2018

Apr 30, 2018

SELL
$70.39 - $84.15 $92,703 - $110,825
-1,317 Reduced 4.87%
25,713 $2.08 Million
Q4 2017

Feb 02, 2018

SELL
$72.33 - $77.64 $274,347 - $294,488
-3,793 Reduced 12.31%
27,030 $2.27 Million
Q3 2017

Oct 24, 2017

BUY
$74.14 - $77.27 $2.29 Million - $2.38 Million
30,823
30,823 $2.65 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $229B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.